Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kui Wan

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|August 14, 2009
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse modelZhao-Kui Wan, Eva Chenail, Jason Xiang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 DiabetesZhao-Kui Wan, Eva Chenail, Huan-Qiu Li, et al.
Chemmedchem|September 18, 2008
Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24Zhao-Kui Wan, Jinbo Lee, Rajeev Hotchandani, et al.
Journal of Medicinal Chemistry|August 21, 2007
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding siteDouglas P Wilson, Zhao-Kui Wan, Wei-Xin Xu, et al.
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Bioorganic & Medicinal Chemistry|April 8, 2020
Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Journal of Medicinal Chemistry|August 17, 2018
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|August 14, 2009
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse modelZhao-Kui Wan, Eva Chenail, Jason Xiang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 DiabetesZhao-Kui Wan, Eva Chenail, Huan-Qiu Li, et al.
Chemmedchem|September 18, 2008
Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24Zhao-Kui Wan, Jinbo Lee, Rajeev Hotchandani, et al.
Journal of Medicinal Chemistry|August 21, 2007
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding siteDouglas P Wilson, Zhao-Kui Wan, Wei-Xin Xu, et al.
Cell Chemical Biology|September 5, 2020
Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein DegradationJing Zhang, Liqiang Fu, Bin Shen, et al.
Bioorganic & Medicinal Chemistry|April 8, 2020
Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Aminopyrazole Carboxamide Bruton's Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group TuningMark E Schnute, Stephen E Benoit, Ingrid P Buchler, et al.
Journal of Medicinal Chemistry|August 17, 2018
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S)-2,2-Difluorocyclopropyl)((1 R,5 S)-3-(2-((1-methyl-1 H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Pageof 4